New York global health researchers and industry leaders gathered Monday in Manhattan to discuss how global health research and development is fueling innovation and saving lives, not to mention funding jobs and companies in the state. Advocates are concerned about the future of U.S. global health investments given President Obama’s fiscal year (FY) 2013 budget […]
The following is a collection of articles, commentary and resources making headlines recently in global health news. Three Reasons Why the World Needs Dr. Jim Kim at the World Bank: Executive Director of RESULTS Joanne Carter penned this op-ed in the Huffington Post, outlining World Bank presidential nominee Dr. Jim Yong Kim’s professional dedication to […]
With little fanfare, the World Health Organization (WHO) recently published a “Programmatic Update” on the use of antiretrovirals (ARVs) to treat pregnant women and prevent mother-to-child transmission of HIV (PMTCT) that identifies Option B and Option B plus as preferable to Option A. Both Option B and Option B+ call for the administration of triple […]
Global health researchers early on in their careers now have a new opportunity for mentored research in a developing country. The National Institutes of Health (NIH) announced Wednesday a new effort to award $20.3 million over the next five years to 400 physicians, veterinarians, dentists and scientists on nearly year-long fellowships at approximately 80 sites […]
Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
Dr. Christoph Benn, director of Resource Mobilization and Donor Relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on the recent tumult at the multilateral organization. Since Columbian banker Gabriel Jaramillo was appointed to head up the Fund in January, the Secretariat has been consumed with “internal […]
The U.S. Department of Health and Human Services (HHS) released updated HIV treatment guidelines on March 27 which, among other things, maintain that all people living with HIV in the U.S. are now eligible to receive antiretroviral therapy (ART), regardless of CD4 cell count. Previous guidance recommended ART for those HIV-infected with a CD4 cell […]
Former tuberculosis (TB) patients from around the world offered a unique glimpse at the impact of the disease on individuals, and the toll it takes on family and friends, by telling their personal stories at an event hosted by The U.S. Agency for International Development (USAID) in late March to honor World TB Day. “Too often we focus on the tragedy – […]